Regulus Reports Second Quarter 2017 Financial Results and Recent Events

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. CVS
5. T
6. UNH
7. AXP
8. VZ
9. PEP
10. RTX

Go back to Regulus Reports Second Quarter 2017 Financial Results and Recent Events

Regulus Therapeutics (RGLS) Misses Q2 EPS by 8c

August 1, 2017 4:38 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) reported Q2 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.

... More